AVAILABLE FALL 2021

Skytrofa Logo
Now Approved text
PRESS RELEASE:
Ascendis Pharma A/S Announces U.S. Food and Drug Administration Approval of SKYTROFA® (lonapegsomatropin-tcgd), the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency
register for updates